The GSK Supported Studies Portal is being upgraded and will be unavailable from Wednesday 27th of January at 5.00PM EST to Tuesday 2nd of February 7.00am EST . If you are anticipating submitting a proposal during this time please submit once the new system is live on the 2nd of February. During this time please contact your Country Medical Point of Contact for any queries. We apologise for any inconvenience.

The Supported Studies Programme

View All Selected

Clear All

In 2022, GSK’s Consumer Healthcare business will become an independent company through a proposed demerger from GSK. As a result, Consumer Healthcare has developed its own Supported Studies portal. Click here to access the portal.

For the latest updates on GSK’s response to COVID-19, please click here.

General Medicines

Timelines

Due to the ongoing global situation, the GSK Respiratory department are not accepting new supported study submissions at this time. Any accepted submissions, where funding has been confirmed, will be progressed as planned. Please contact your local GSK office if you require further information. We are constantly reviewing our position and will publish updates at this site should things change. Thank you

Although GSK are more likely to support studies aligned to our current areas of interest for supported studies, we are interested in supporting studies that are innovative and contribute to scientific knowledge relating to a product, a medical condition or advancing a technology.